Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Oncology|June 20, 2018
Use of Gene Expression Analysis for Discrimination of Primary and Secondary Adenocarcinoma of the LiverHolger G Hass, Ulrich Vogel, Michael Scheurlen, et al.Anticancer Research|November 1, 2016
Gene-expression Analysis Identifies Specific Patterns of Dysregulated Molecular Pathways and Genetic Subgroups of Human Hepatocellular CarcinomaHolger G Hass, Ulrich Vogel, Michael Scheurlen, et al.Gut and Liver|December 23, 2017
Subclassification and Detection of New Markers for the Discrimination of Primary Liver Tumors by Gene Expression Analysis Using Oligonucleotide ArraysHolger G Hass, Ulrich Vogel, Michael Scheurlen, et al.Oral Oncology|March 14, 2007
DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisionsHolger G Hass, Andreas Schmidt, Oliver Nehls, et al.Journal of Gastroenterology|May 22, 2009
Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis BHolger G Hass, Thomas Bock, Oliver Nehls, et al.Journal of Clinical Gastroenterology|February 28, 2009
Thyroid disorders and occurrence of nonorgan-specific autoantibodies (NOSA) in patients with chronic hepatitis C before and during antiviral induction therapy with consensus interferon (interferon alfacon-1)Holger G Hass, Reinhild Klein, Oliver Nehls, et al.Oncology Research and Treatment|October 20, 2022
Male Breast Cancer: Therapy-Induced Toxicities, Psychological Distress, and Individual Patient Goals during Oncological Inpatient RehabilitationHolger G Hass, Andrea Herzberger, Achim Wöckel, et al.Oncology Research and Treatment|December 23, 2014
Overexpression of tumor-associated trypsin inhibitor (SPINK1/TATI) in hepatitis C-associated hepatocellular carcinoma: potential implications for viral hepatocarcinogenesisHolger G Hass, Jürgen Jobst, Ulrich Vogel, et al.World Journal of Gastroenterology|September 9, 2005
High-dose interferon-alpha2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-alpha monotherapyHolger-G Hass, Christian Kreysel, Johannes Fischinger, et al.Pageof 3